LabCorp 2009 Annual Report Download - page 5

Download and view the complete annual report

Please find page 5 of the 2009 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 66

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66

Esoteric
Testing
LabCorp is at the forefront of esoteric testing with an
ever-expanding portfolio of leading-edge tests that help
improve the treatment of patients. We were the fi rst national
laboratory to recognize the potential of genomic testing to
improve patient diagnosis, care and treatment. Today, one of
our fastest-growing tests is for vitamin D defi ciency, which has
become one of the most cost-effective medical interventions
in the United States. The vitamin D test provides the most
accurate method for measuring vitamin D defi ciency, which is
linked to osteoporosis, colon, prostate and breast cancers
and autoimmune conditions, such as multiple sclerosis. Other
recent additions to our esoteric testing portfolio include the
HERmark® Breast Cancer test, which is more sensitive than
the traditional HER-2/neu test and identifi es breast cancer
patients who will be receptive to Herceptin® therapy, and our
BRAF Gene Mutation Detection test which identifi es mutations
that are common in melanomas and colo-rectal, lung and other
cancers. LabCorp remains committed to capitalizing on its
scientifi c leadership to commercialize tests that provide
physicians with insights into treatment of disease.
LABORATORY CORPORATION OF AMERICA 3
SCIENTIFIC LEADERSHIP
Results